ICU

SeaStar Medical (ICU)

SeaStar Medical Holding Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ICU

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/22	21 : 30	GlobeNewswire Inc.	Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/05/15	05 : 05	GlobeNewswire Inc.	SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/04/30	21 : 30	GlobeNewswire Inc.	SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/04/18	05 : 00	GlobeNewswire Inc.	SeaStar Medical Reports 2023 Financial Results and Provides a Business Update	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/04/11	21 : 30	GlobeNewswire Inc.	SeaStar Medical to Present at the Noble Capital Markets’ Emerging Growth Virtual Healthcare Equity Conference	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/03/27	21 : 30	GlobeNewswire Inc.	SeaStar Medical to Restate Financials, Sets Business Update Call for April 17	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/03/12	21 : 30	GlobeNewswire Inc.	SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/03/12	05 : 05	GlobeNewswire Inc.	SeaStar Medical-Sponsored Symposium Featuring Experts Discussing Pediatric Acute Kidney Injury and the Selective Cytopheretic Device to be Webcast Live at AKI & CRRT 2024	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/02/27	22 : 30	GlobeNewswire Inc.	Manuscript Discussing the Benefit of SeaStar Medical’s Selective Cytopheretic Device in Patients with Heart Failure and Hyperinflammation Published in European Journal of Heart Failure	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/02/22	21 : 58	GlobeNewswire Inc.	Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/02/22	21 : 53	GlobeNewswire Inc.	FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/02/01	22 : 30	GlobeNewswire Inc.	SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/01/26	22 : 05	GlobeNewswire Inc.	SeaStar Medical Announces Pricing of $9.0 Million Registered Direct Offering Priced At-the-Market	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/01/12	06 : 05	GlobeNewswire Inc.	SeaStar Medical Appoints David A. Green as Chief Financial Officer	NASDAQ:ICU	SeaStar Medical Holding Corporation
2024/01/09	22 : 30	GlobeNewswire Inc.	SeaStar Medical Issued U.S. Patent with Broad Claims Covering Use of the Selective Cytopheretic Device for Multiple Clinical Indications	NASDAQ:ICU	SeaStar Medical Holding Corporation
2023/12/28	22 : 30	GlobeNewswire Inc.	SeaStar Medical Updates Subject Enrollment in its Pivotal Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury	NASDAQ:ICU	SeaStar Medical Holding Corporation
2023/12/13	22 : 30	GlobeNewswire Inc.	SeaStar Medical Forms Scientific Advisory Board of World-Renowned Pediatric and Adult Clinical Experts	NASDAQ:ICU	SeaStar Medical Holding Corporation
2023/11/15	06 : 04	GlobeNewswire Inc.	SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update	NASDAQ:ICU	SeaStar Medical Holding Corporation
2023/10/31	21 : 00	GlobeNewswire Inc.	Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device	NASDAQ:ICU	SeaStar Medical Holding Corporation
2023/10/30	21 : 00	GlobeNewswire Inc.	FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients	NASDAQ:ICU	SeaStar Medical Holding Corporation
2023/10/18	21 : 30	GlobeNewswire Inc.	FDA Grants SeaStar Medical’s Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal Syndrome	NASDAQ:ICU	SeaStar Medical Holding Corporation
2023/10/05	21 : 30	GlobeNewswire Inc.	SeaStar Medical to Present at the Dawson James Small Cap Growth Conference on October 12, 2023	NASDAQ:ICU	SeaStar Medical Holding Corporation
2023/10/04	05 : 05	GlobeNewswire Inc.	SeaStar Medical Provides Regulatory Update Regarding Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under a Humanitarian Device Exemption	NASDAQ:ICU	SeaStar Medical Holding Corporation
2023/09/29	21 : 30	GlobeNewswire Inc.	FDA Grants Breakthrough Device Designation to SeaStar Medical’s Selective Cytopheretic Device for Cardiorenal Syndrome	NASDAQ:ICU	SeaStar Medical Holding Corporation
2023/09/21	22 : 35	GlobeNewswire Inc.	Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference	NASDAQ:ICU	SeaStar Medical Holding Corporation
2023/08/31	05 : 35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ICU	SeaStar Medical Holding Corporation
2023/08/29	21 : 00	GlobeNewswire Inc.	Case Series of Three Critically Ill Children with Acute Kidney Injury Safely Treated with SeaStar Medical’s Selective Cytopheretic Device Published in the Journal Blood Purification	NASDAQ:ICU	SeaStar Medical Holding Corporation
2023/08/25	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ICU	SeaStar Medical Holding Corporation
2023/08/22	21 : 00	GlobeNewswire Inc.	SeaStar Medical to Hold Business Update Conference Call Today at 4:00 p.m. Eastern Time	NASDAQ:ICU	SeaStar Medical Holding Corporation
2023/08/18	06 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ICU	SeaStar Medical Holding Corporation